Conclusion: This review suggests that adjunctive HupA is an effective choice for improving cognitive function for patients with schizophrenia spectrum disorders. More well-designed RCTs are needed to further confirm HupA's efficacy. Copyright © 2016 John Wiley & Sons, Ltd.
PubMed 27302211 ↗Huperzine a
The short answer. More people than not who report on Huperzine a say it helped (56% of 96). It is most often used for focus: 88% of 48 reports say that improved. It is well studied — 18 meta-analyses on PubMed. The most common complaint is vivid dreams.
From 301 mentions in total — the rest didn't say how it went and aren't counted.
What Huperzine a does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 18 meta-analyses on PubMed ↗ · 14 randomized trials ↗
Conclusion: Huperzine A appears to have beneficial effects on improvement of cognitive function, daily living activity, and global clinical assessment in participants with Alzheimer's disease. However, the findings should be interpreted with caution due to the poor methodological quality of the included trials.
PubMed 24086396 ↗Conclusion: This study enhances the understanding of the relative benefits and risks associated with various VaD treatments, providing a valuable reference for clinical decision-making.
PubMed 39239652 ↗Conclusion: There is no [convincing] evidence that Huperzine A is of value in vascular dementia based on one small trial. It deserves further research.
PubMed 19370686 ↗23 human trials on ClinicalTrials.gov test Huperzine a — 9 completed, 4 recruiting now. See all on ClinicalTrials.gov ↗
- The Study of Pharmacokinetics and Pharmacodynamics of Huperzine A Injection in Healthy Chinese Subjects · Healthy Subjects · 2024
- Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects · Healthy Volunteer · 2022
- Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise · Cognitive Enhancement During Exercise · 2018
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
5 reports name a product containing Huperzine a (2009–2026); 4 involved hospitalization or worse. Most often reported:
- Dizziness · 2
- Nausea · 2
- Paraesthesia · 1
- Dyspnoea · 1
- Anaphylactic shock · 1
- Shock · 1
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 8 research projects with Huperzine a in the title, $3,653,236 in total (2000–2012). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Huperzine a 250mcg a day fixed my dad right up. It's actually the same med and dosage used in China for dementia.”
“Huperzine-A - I initially took it for lucid dreaming, but it is a complete flop for me. Nothing changed. No vivid dreams, no brain function improvement. Nothing.”
“Huperzine A is absolutely magical for me... It increases REM phase of sleep => longer and more vivid dreams & feeling more recharged in the morning.”
“Huperzine A works for me. Restores sensitivity to modafinil, nicotine. Phenibut. 100-200mcg used the day before. Next day sensitivity is higher and tolerance lower.”
Top discussions (5)
- My dad’s memory is in decline. Please help. ↗
- 20 Years of trying Nootropics - This blew them all away: ↗
- 20 Years of Trying Nootropics : Now Identified Apigenin from Chamomile ↗
- Switching between galantamine & huperzine-a possible without tolerance build up? ↗
- The oral bioavailability of EVERY nootropic (84+) ↗
Huperzine a compared
Other options for focus
Sources
- User reports: 301 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate